Overview

PTC Study to Evaluate Ataluren in Combination With Ivacaftor

Status:
Completed
Trial end date:
2018-12-31
Target enrollment:
Participant gender:
Summary
The purpose of this study is to explore the combination of ataluren and ivacaftor as a treatment for patients with nonsense mutation cystic fibrosis
Phase:
Phase 4
Details
Lead Sponsor:
University of Alabama at Birmingham